Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gian Franco Gensini , Camilla Alderighi , Raffaele Rasoini , et al Added: 3 years ago
Telehealth is a multiform term embracing the applications of telematics to medicine, in order to enable diagnosis and/or treatment remotely through a set of communication tools, including phones, smartphones and mobile wireless devices, with or without a video connection.1 Until a few years ago, digital applications in medicine were restricted to the use of data obtained from electronic health… View more
Author(s): Mohammad S Alzahri , Anita Rohra , W Frank Peacock Added: 3 years ago
Acute heart failure (AHF) presents symptoms primarily the result of pulmonary congestion due to elevated left ventricular (LV) filling pressures with or without reduced ejection fraction (EF). Common precipitating pathology includes coronary artery disease (CAD), hypertension and valvular heart diseases, in addition to other noncardiac conditions, such as diabetes, anaemia and kidney dysfunction… View more
Author(s): John Boehmer Added: 1 year ago
ACC.23/WCC –We are joined on-site by Dr John Boehmer (Penn State Health, US) to discuss the findings of the BMAD-TX Trial, originally revealed at ACC 2023 (Zoll Medical Corporation). In this study, investigators aimed to assess the impact of a novel wearable sensor, the Microcor, (μCor™) in the management of heart failure. 266 patients with ambulatory decompensated heart failure were enrolled in… View more
Author(s): Izabella Uchmanowicz , Agnieszka Młynarska , Magdalena Lisiak , et al Added: 3 years ago
The first paper that referred to the problem of ‘frail elderly patients’ was published in 1953, and frailty syndrome (FS) was first described in the 1990s.1,2 Although it has long been recognised and diagnosed, no consensus definition of this clinical syndrome has been established. The Second International Working Meeting on Frailty and Aging in 2006 concluded that FS involves increased… View more
Author(s): Mikhail Kosiborod Added: 1 year ago
In this short video we asked Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) about the key heart failure highlights of 2022 and his thoughts on what comes next in HF treatment and research. Recorded at Heart Failure 2022, Madrid. View more
Author(s): Pierpaolo Pellicori , Kuldeep Kaur , Andrew L Clark Added: 3 years ago
Heart failure (HF) is one of the most common reasons for admission to hospital. It is associated with long in-patient stays, and has a high in-hospital and post-discharge morbidity and mortality, whether left ventricular ejection fraction (LVEF) is reduced (HFREF) or normal (HeFNEF).1,2 Congestion, or fluid overload, is a classic clinical feature of patients presenting with HF. In some patients,… View more
Author(s): Gianluigi Savarese , Lars H Lund Added: 3 years ago
Heart failure (HF) is a complex clinical syndrome characterised by the reduced ability of the heart to pump and/or fill with blood.1,2 From a physiological point of view, HF can be defined as an inadequate cardiac output to meet metabolic demands or adequate cardiac output secondary to compensatory neurohormonal activation (generally manifesting as increased left ventricular filling pressure).2… View more
Author(s): Joe Gallagher , Chris Watson , Patricia Campbell , et al Added: 3 years ago
Increasingly biomarkers are of interest in cardiovascular disease (CVD) for risk stratification. In particular, natriuretic peptides (NPs), which were originally used for the diagnosis of heart failure, are now finding a role in identifying those most at risk of heart failure and other cardiovascular (CV) disorders. Their ability to be measured rapidly through blood tests makes their widespread… View more